+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Olympus Corp (7733) - Product Pipeline Analysis, 2022 Update

1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Olympus Corp (Olympus) is a manufacturer of optical and digital precision machinery and instruments. The company develops, manufactures and markets equipment and devices for medical, healthcare, imaging, information, and other industrial markets. It offers medical systems such as endotherapy devices, endoscopes and endoscopy products, to help healthcare professionals treat patients; scientific solutions such as laser scanning microscopes, industrial and biological microscope systems, and remote visual inspection products and non-destructive testing systems. It also offers biomedical materials and system development services. Through its subsidiaries and facilities, the company operates in the Americas, Europe, and Asia-Pacific. Olympus Corp is headquartered in Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Olympus Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Olympus Corp Company Overview
  • Olympus Corp Company Snapshot
  • Olympus Corp Pipeline Products and Ongoing Clinical Trials Overview
  • Olympus Corp - Pipeline Analysis Overview
  • Business Description
  • Olympus Corp - Key Facts
  • Olympus Corp - Majo

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Dextera Surgical Inc
  • Hoya Corp
  • KARL STORZ SE & Co KG
  • Konica Minolta Inc
  • Nikon Corp
  • Precision Optics Corporation Inc
  • The Cooper Companies Inc